NGL Fine Chem

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE887E01022
NSEID: NGLFINE
BSEID: 524774

INR

1,261.00

-40.05 (-3.08%)

BSENSE

Dec 05

BSE+NSE Vol: 14

{
  "main_header": {
    "sid": 700623,
    "name": "NGL Fine Chem",
    "stock_name": "NGL Fine Chem",
    "full_name": "NGL Fine Chem Ltd",
    "name_url": "stocks-analysis/ngl-fine-chem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,261.00",
    "chg": -40.05,
    "chgp": "-3.08%",
    "dir": -1,
    "prev_price": "1,301.05",
    "mcapval": "779.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524774,
    "symbol": "NGLFINE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE887E01022",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "14 ",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ngl-fine-chem-700623-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Is NGL Fine Chem technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ngl-fine-chem-technically-bullish-or-bearish-3745353",
        "imagepath": "",
        "date": "2025-12-04 08:26:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Technical Trend Shift</strong></p>\n<p>As of 3 December 2025, NGL Fine Chem’s technical trend transitioned from mildly bullish to mildly bearish. This shift signals a cautious stance among traders and investors, reflecting growing uncertainty or potential downward momentum in the near term. Such a change often prompts market participants to reassess their positions, especially in a sector as sensitive as pharmaceuticals and biotechnology.</p>\n<p><strong>Key Technical Indicators Overview</strong></p>\n<p>Examining the primary technical indicators provides a nuanced picture of the stock’s momentum and potential direction:</p>\n<ul>\n<li><strong>MACD (Moving Average Convergence Divergence):</strong> The weekly MACD is mildly bearish, suggesting short-term momentum is weakening. However, the ..."
      },
      {
        "title": "NGL Fine Chem Faces Shift in Market Assessment Amidst Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ngl-fine-chem-downgraded-to-sell-amid-weak-financials-and-bearish-technicals-3745488",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NGLFineChem_mojoScore_3745488.png",
        "date": "2025-12-04 08:10:10",
        "description": "NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its market evaluation following recent changes across multiple analytical parameters. The company’s financial performance, valuation metrics, technical indicators, and quality measures collectively contribute to a revised perspective on its investment profile."
      },
      {
        "title": "NGL Fine Chem Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-faces-technical-setback-amid-price-momentum-shift-3745460",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NGLFineChem_technicaldot_3745460.png",
        "date": "2025-12-04 08:08:48",
        "description": "NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of indicator signals. Recent market data reveals a transition from mildly bullish to mildly bearish trends, underscoring a nuanced market assessment for the stock as it navigates fluctuating price dynamics and technical parameters."
      },
      {
        "title": "How has been the historical performance of NGL Fine Chem?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ngl-fine-chem-3744725",
        "imagepath": "",
        "date": "2025-12-03 22:49:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Over the seven-year period ending March 2025, NGL Fine Chem’s net sales exhibited a robust upward trend, rising from ₹153.17 crores in 2018-19 to ₹368.26 crores in 2024-25. This represents a compound growth trajectory, albeit with some volatility, such as a dip in 2020-21 followed by a recovery. Total operating income mirrored this pattern, reflecting the company’s core business expansion.</p>\n<p>Operating profit before depreciation and interest (PBDIT excluding other income) showed considerable variation, peaking at ₹79.74 crores in 2020-21 before declining to ₹33.87 crores in 2024-25. Including other income, operating profit followed a similar pattern, reaching a high of ₹87.76 crores in 2020-21 and settling at ₹42.50 crores in the latest fi..."
      },
      {
        "title": "NGL Fine Chem Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-technical-momentum-shifts-signal-mild-bullish-outlook-amid-mixed-indicators-3737486",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NGLFineChem_technicaldot_3737486.png",
        "date": "2025-12-01 08:02:55",
        "description": "NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This development comes amid a complex backdrop of mixed signals from various technical indicators, reflecting a nuanced market assessment for the stock as it navigates current price levels and broader sector dynamics."
      },
      {
        "title": "NGL Fine Chem Surges to Upper Circuit Amidst Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-hits-upper-circuit-amidst-unprecedented-buying-interest-3733046",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NGLFineChem_only_buyers_3733046.png",
        "date": "2025-11-27 09:50:57",
        "description": "NGL Fine Chem has witnessed extraordinary buying momentum, hitting the upper circuit with a queue composed solely of buy orders. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, capturing the attention of investors and market watchers alike."
      },
      {
        "title": "NGL Fine Chem Hits Upper Circuit Amidst Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ngl-fine-chem-hits-upper-circuit-amidst-unprecedented-buying-interest-3717454",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NGLFineChem_only_buyers_3717454.png",
        "date": "2025-11-20 09:50:49",
        "description": "NGL Fine Chem Ltd has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and only buy orders queued on the exchange. This rare market phenomenon highlights intense demand and the absence of sellers, signalling a potential multi-day circuit scenario for the Pharmaceuticals & Biotechnology company."
      },
      {
        "title": "NGL Fine Chem: Analytical Review Highlights Financial and Technical Shifts Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ngl-fine-chem-downgraded-to-sell-amidst-flat-financials-and-weak-technicals-3717108",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NGLFineChem_mojoScore_3717108.png",
        "date": "2025-11-20 08:09:25",
        "description": "NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its evaluation reflecting shifts across quality, valuation, financial trends, and technical indicators. This comprehensive analysis explores the factors influencing the company's current market standing and performance metrics amid a challenging industry backdrop."
      },
      {
        "title": "How has been the historical performance of NGL Fine Chem?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ngl-fine-chem-3716178",
        "imagepath": "",
        "date": "2025-11-19 22:41:57",
        "description": "Answer:\nThe historical performance of NGL Fine Chem shows a fluctuating trend in key financial metrics over the years.\n\nBreakdown:\nNGL Fine Chem's net sales have generally increased from INR 151.69 crore in March 2020 to INR 368.26 crore in March 2025, with a notable dip in March 2022 to INR 317.50 crore. The total operating income followed a similar trajectory, reaching INR 368.26 crore in March 2025. However, total expenditure, excluding depreciation, rose significantly from INR 132.30 crore in March 2020 to INR 334.39 crore in March 2025. Operating profit (PBDIT) saw a peak of INR 87.76 crore in March 2021 but decreased to INR 42.50 crore by March 2025. Profit before tax mirrored this trend, peaking at INR 77.59 crore in March 2021 and dropping to INR 27.71 crore in March 2025. Profit after tax also fluctuated, reaching a high of INR 56.72 crore in March 2021 and declining to INR 21.12 crore in March 202..."
      }
    ],
    "total": 453,
    "sid": "700623",
    "stock_news_url": "https://www.marketsmojo.com/news/ngl-fine-chem-700623"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "20-Nov-2025",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the Company participated in the Investors Conference Call on Tuesday 18th November 2025 enclosed herewith please find transcript of earnings conference call on unaudited Financial Results for the Quarter and half year ended on 30th September 2025. No unpublished price sensitive information was shared/discussed in the meeting. Please note that this was a group meet.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "18-Nov-2025",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the Company participated in the Investors Conference Call today i.e. Tuesday 18th November 2025 on unaudited financial results for the 2nd quarter and half year ended September 30 2025. No unpublished price sensitive information was shared/discussed in the meeting. Audio of the conference call has been uploaded at the Companys website: https://www.nglfinechem.com/images/10037838.mp3",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2025",
      "details": "Newspaper Pulication",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "NGL Fine Chem Ltd has declared <strong>35%</strong> dividend, ex-date: 12 Aug 25",
          "dt": "2025-08-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is NGL Fine Chem technically bullish or bearish?

2025-12-04 08:26:19

Recent Technical Trend Shift

As of 3 December 2025, NGL Fine Chem’s technical trend transitioned from mildly bullish to mildly bearish. This shift signals a cautious stance among traders and investors, reflecting growing uncertainty or potential downward momentum in the near term. Such a change often prompts market participants to reassess their positions, especially in a sector as sensitive as pharmaceuticals and biotechnology.

Key Technical Indicators Overview

Examining the primary technical indicators provides a nuanced picture of the stock’s momentum and potential direction:

MACD (Moving Average Convergence Divergence): The weekly MACD is mildly bearish, suggesting short-term momentum is weakening. However, the ...
Read More

NGL Fine Chem Faces Shift in Market Assessment Amidst Mixed Financial and Technical Signals

2025-12-04 08:10:10

NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its market evaluation following recent changes across multiple analytical parameters. The company’s financial performance, valuation metrics, technical indicators, and quality measures collectively contribute to a revised perspective on its investment profile.

NGL Fine Chem Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-04 08:08:48

NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of indicator signals. Recent market data reveals a transition from mildly bullish to mildly bearish trends, underscoring a nuanced market assessment for the stock as it navigates fluctuating price dynamics and technical parameters.

How has been the historical performance of NGL Fine Chem?

2025-12-03 22:49:01

Revenue and Profitability Trends

Over the seven-year period ending March 2025, NGL Fine Chem’s net sales exhibited a robust upward trend, rising from ₹153.17 crores in 2018-19 to ₹368.26 crores in 2024-25. This represents a compound growth trajectory, albeit with some volatility, such as a dip in 2020-21 followed by a recovery. Total operating income mirrored this pattern, reflecting the company’s core business expansion.

Operating profit before depreciation and interest (PBDIT excluding other income) showed considerable variation, peaking at ₹79.74 crores in 2020-21 before declining to ₹33.87 crores in 2024-25. Including other income, operating profit followed a similar pattern, reaching a high of ₹87.76 crores in 2020-21 and settling at ₹42.50 crores in the latest fi...

NGL Fine Chem Technical Momentum Shifts Amid Mixed Market Signals

2025-12-01 08:02:55

NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a subtle shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This development comes amid a complex backdrop of mixed signals from various technical indicators, reflecting a nuanced market assessment for the stock as it navigates current price levels and broader sector dynamics.

NGL Fine Chem Surges to Upper Circuit Amidst Unprecedented Buying Interest

2025-11-27 09:50:57

NGL Fine Chem has witnessed extraordinary buying momentum, hitting the upper circuit with a queue composed solely of buy orders. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, capturing the attention of investors and market watchers alike.

NGL Fine Chem Hits Upper Circuit Amidst Unprecedented Buying Interest

2025-11-20 09:50:49

NGL Fine Chem Ltd has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and only buy orders queued on the exchange. This rare market phenomenon highlights intense demand and the absence of sellers, signalling a potential multi-day circuit scenario for the Pharmaceuticals & Biotechnology company.

NGL Fine Chem: Analytical Review Highlights Financial and Technical Shifts Amid Market Challenges

2025-11-20 08:09:25

NGL Fine Chem, a key player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its evaluation reflecting shifts across quality, valuation, financial trends, and technical indicators. This comprehensive analysis explores the factors influencing the company's current market standing and performance metrics amid a challenging industry backdrop.

How has been the historical performance of NGL Fine Chem?

2025-11-19 22:41:57

Answer: The historical performance of NGL Fine Chem shows a fluctuating trend in key financial metrics over the years. Breakdown: NGL Fine Chem's net sales have generally increased from INR 151.69 crore in March 2020 to INR 368.26 crore in March 2025, with a notable dip in March 2022 to INR 317.50 crore. The total operating income followed a similar trajectory, reaching INR 368.26 crore in March 2025. However, total expenditure, excluding depreciation, rose significantly from INR 132.30 crore in March 2020 to INR 334.39 crore in March 2025. Operating profit (PBDIT) saw a peak of INR 87.76 crore in March 2021 but decreased to INR 42.50 crore by March 2025. Profit before tax mirrored this trend, peaking at INR 77.59 crore in March 2021 and dropping to INR 27.71 crore in March 2025. Profit after tax also fluctuated, reaching a high of INR 56.72 crore in March 2021 and declining to INR 21.12 crore in March 202...

View All News

Announcement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

20-Nov-2025 | Source : BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the Company participated in the Investors Conference Call on Tuesday 18th November 2025 enclosed herewith please find transcript of earnings conference call on unaudited Financial Results for the Quarter and half year ended on 30th September 2025. No unpublished price sensitive information was shared/discussed in the meeting. Please note that this was a group meet.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

18-Nov-2025 | Source : BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we wish to inform you that the Company participated in the Investors Conference Call today i.e. Tuesday 18th November 2025 on unaudited financial results for the 2nd quarter and half year ended September 30 2025. No unpublished price sensitive information was shared/discussed in the meeting. Audio of the conference call has been uploaded at the Companys website: https://www.nglfinechem.com/images/10037838.mp3